EUVIMEDEUVIMED entdecken
Open Access

Ameliorative Effects of a Naphthoquinone Derivative With β‐Amyloid Aggregation Inhibitory Activity on Cognitive Impairment and Metabolite Analysis of the Blood and Brains of Mice

Jong Min Oh, Won Kyeong Jeong, Hyun Ju Son, Seo Young Kim, Tae Woo Oh iD, Moongi Ji, Ji Woo Nam, Minyeong Baek, Jeong-Ho Park, Woong-Hee Shin iD, Hee Jung Kim, Byeongchan Choi und 2 weitere

Drug Development Research · 2026

DOI: 10.1002/ddr.70345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von Jong Min Oh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, Sunchon National University, Suncheon, Republic of Korea. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Naphthoquinones, Cognitive Dysfunction, Neuroprotective Agents. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulation of amyloid‐β (Aβ) plaques is an important cause of Alzheimer's disease (AD) pathogenesis. In this study, we evaluated Aβ aggregation inhibitory activity of synthesized naphthoquinone derivatives as well as improvement in cognitive functions and metabolite profiling of brain tissues using scopolamine (SCO)‐induced mice. Compound 888 (2‐(4‐(2,3,4‐trimethoxybenzyl)piperazin‐1‐yl)naphthalene‐1,4‐dione, [TPN]) showed the highest Aβ aggregation inhibitory activity (IC 50 = 0.14 μM), and was more potent than the reference compound curcumin (IC 50 = 1.63 μM). Compound TPN showed effective monoamine oxidase (MAO)‐A, MAO‐B, acetylcholinesterase, and butyrylcholinesterase inhibitions at 10 μM, likely as candidates for multitarget‐directed ligands. TPN was permeable through the blood‐brain barrier, and non‐toxic to MDCK and SH‐SY5Y cells. TPN displayed prolonged and stable interactions with Aβ 42 during molecular dynamics simulations, in contrast to the short‐lived contacts observed for curcumin. Cognitive impairment was significantly improved by TPN‐treatment in behavioral tests. TPN treatment attenuated Aβ‐related protein expression, inflammatory responses, oxidative stress‐related changes, and apoptosis‐related alterations, while preserving hippocampal pyramidal neurons and their typical morphology. In metabolite profiling, TPN modulated a narrower set of pathways mainly related to amino acid and kynurenine metabolism, whereas donepezil induced broader adjustments involving amino acid, mitochondrial/energy, and lipid‐related pathways compared to those in the serum and cortex of the SCO group, in contrast to those in the hippocampus. Collectively, a potent Aβ aggregation inhibitor TPN showed significant cognitive improvement, accompanying by neuroprotective effects, decreasing inflammation, and retaining neuron structures, exhibiting changed metabolic profiles compared to the control treatments. These findings suggest that TPN has cognitive‐protective and neuroprotective potential under scopolamine‐induced impairment conditions and warrants further validation in AD‐relevant models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesNaphthoquinonesCognitive DysfunctionNeuroprotective AgentsAnimalsMiceBrainMaleHumansPeptide FragmentsAlzheimer DiseaseScopolamineMadin Darby Canine Kidney CellsCognitive Enhancement

Stichwörter der Autor:innen

2‐(4‐(2,3,4‐trimethoxybenzyl)piperazin‐1‐yl)naphthalene‐1,4‐dioneAβ aggregation inhibitory activityWestern blottingmetabolite profilingmolecular dynamics simulationmouse behavioral tests

Substanzen

Amyloid beta-PeptidesNaphthoquinonesPeptide FragmentsScopolamineNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmacy, College of Pharmacy, Sunchon National University, Suncheon, Republic of Korea.
  • Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, Naju, Republic of Korea.
  • Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu, Republic of Korea.
  • University of Science and Technology (UST), Korean Convergence Medicine Major KIOM, Daejeon, Republic of Korea.
  • Department of Chemical & Biological Engineering, Hanbat National University, Daejeon, Republic of Korea.
  • Department of Biomedical Informatics, College of Medicine, Korea University, Seoul, Republic of Korea.

ORCID-Profile: Tae Woo Oh, Woong-Hee Shin

Förderung

  • National Research Foundation of Korea (NRF)

Zitieren

APA

Oh, J. M., Jeong, W. K., Son, H. J., Kim, S. Y., Oh, T. W., Ji, M., Nam, J. W., Baek, M., Park, J. H., Shin, W. H., Kim, H. J., Choi, B., Paik, M. J., & Kim, H. (2026). Ameliorative Effects of a Naphthoquinone Derivative With β‐Amyloid Aggregation Inhibitory Activity on Cognitive Impairment and Metabolite Analysis of the Blood and Brains of Mice. Drug Development Research. https://doi.org/10.1002/ddr.70345

Vancouver

Oh JM, Jeong WK, Son HJ, Kim SY, Oh TW, Ji M, et al. Ameliorative Effects of a Naphthoquinone Derivative With β‐Amyloid Aggregation Inhibitory Activity on Cognitive Impairment and Metabolite Analysis of the Blood and Brains of Mice. Drug Development Research. 2026. doi:10.1002/ddr.70345

BibTeX
@article{Oh2026,
  author = {Oh, Jong Min and Jeong, Won Kyeong and Son, Hyun Ju and Kim, Seo Young and Oh, Tae Woo and Ji, Moongi and Nam, Ji Woo and Baek, Minyeong and Park, Jeong-Ho and Shin, Woong-Hee and Kim, Hee Jung and Choi, Byeongchan and Paik, Man-Jeong and Kim, Hoon},
  title = {Ameliorative Effects of a Naphthoquinone Derivative With β‐Amyloid Aggregation Inhibitory Activity on Cognitive Impairment and Metabolite Analysis of the Blood and Brains of Mice},
  journal = {Drug Development Research},
  year = {2026},
  doi = {10.1002/ddr.70345}
}
Kostenlos starten →